


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:37Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406811" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406811</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmjo</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="pmc-domain-id">1609</journal-id><journal-id journal-id-type="pmc-domain">bmjo</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406811</article-id><article-id pub-id-type="pmcid-ver">PMC12406811.1</article-id><article-id pub-id-type="pmcaid">12406811</article-id><article-id pub-id-type="pmcaiid">12406811</article-id><article-id pub-id-type="pmid">40897474</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2025-100361</article-id><article-id pub-id-type="publisher-id">bmjopen-2025-100361</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Protocol</subject></subj-group><subj-group subj-group-type="heading"><subject>Surgery</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1737</subject><subject>1506</subject></subj-group></article-categories><title-group><article-title>Assessing the global variation in patient characteristics, management and short-term outcomes of spontaneous intracranial haemorrhage worldwide: a protocol for a global observational prospective multicentre study (the PLOT-ICH study)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9541-0090</contrib-id><name name-style="western"><surname>Venturini</surname><given-names initials="S">Sara</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clark</surname><given-names initials="D">David</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8471-1368</contrib-id><name name-style="western"><surname>Smith</surname><given-names initials="BG">Brandon George</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hobbs</surname><given-names initials="L">Laura</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1879-1093</contrib-id><name name-style="western"><surname>Bath</surname><given-names initials="MF">Michael F</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mee</surname><given-names initials="H">Harry</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Still</surname><given-names initials="M">Megan</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mediratta</surname><given-names initials="S">Saniya</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Soliman</surname><given-names initials="MA">Mohamed Amin</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1919-0193</contrib-id><name name-style="western"><surname>Kohler</surname><given-names initials="K">Katharina</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9767-2123</contrib-id><name name-style="western"><surname>Whiffin</surname><given-names initials="CJ">Charlotte Jane</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Katambo</surname><given-names initials="E">Elijah</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korhonen</surname><given-names initials="TK">Tommi K</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tetri</surname><given-names initials="S">Sami</given-names></name><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4277-9767</contrib-id><name name-style="western"><surname>Bankole</surname><given-names initials="NDA">Nourou Dine Adeniran</given-names></name><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rutabasibwa</surname><given-names initials="N">Nicephorus</given-names></name><xref rid="aff9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bhebhe</surname><given-names initials="A">Arnold</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Munusamy</surname><given-names initials="T">Thangaraj</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tirsit</surname><given-names initials="A">Abenezer</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="KB">Kee B</given-names></name><xref rid="aff12" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Budohoski</surname><given-names initials="K">Karol</given-names></name><xref rid="aff13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wahjoepramono</surname><given-names initials="P">Petra</given-names></name><xref rid="aff14" ref-type="aff">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tamborska</surname><given-names initials="A">Arina</given-names></name><xref rid="aff15" ref-type="aff">15</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saylor</surname><given-names initials="D">Deanna</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khan</surname><given-names initials="T">Tariq</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff16" ref-type="aff">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khattak</surname><given-names initials="AF">Almas Fasih</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff16" ref-type="aff">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Figaji</surname><given-names initials="A">Anthony</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff17" ref-type="aff">17</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3992-0587</contrib-id><name name-style="western"><surname>Kolias</surname><given-names initials="AG">Angelos G</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0228-9779</contrib-id><name name-style="western"><surname>Bashford</surname><given-names initials="T">Tom</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Joannides</surname><given-names initials="A">Alexis</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff18" ref-type="aff">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martin</surname><given-names initials="M">Michael</given-names></name><xref rid="aff18" ref-type="aff">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Trivedi</surname><given-names initials="RA">Rikin A</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2796-1835</contrib-id><name name-style="western"><surname>Hutchinson</surname><given-names initials="PJ">Peter J</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><collab>on behalf of the PLOT-ICH Collaborative</collab></contrib><aff id="aff1"><label>1</label><institution content-type="department">NIHR Global Health Research Group on Acquired Brain and Spine Injury</institution>, <institution>University of Cambridge</institution>, <addr-line content-type="city">Cambridge</addr-line>, <country>UK</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Department of Neurosurgery</institution>, <institution>University of Florida</institution>, <addr-line content-type="city">Gainesville</addr-line>, <addr-line content-type="state">Florida</addr-line>, <country>USA</country></aff><aff id="aff3"><label>3</label><institution>Cairo University</institution>, <addr-line content-type="city">Cairo</addr-line>, <country>Egypt</country></aff><aff id="aff4"><label>4</label><institution>University at Buffalo</institution>, <addr-line content-type="city">Buffalo</addr-line>, <addr-line content-type="state">New York</addr-line>, <country>USA</country></aff><aff id="aff5"><label>5</label><institution content-type="department">College of Health of Social Care</institution>, <institution>University of Derby</institution>, <addr-line content-type="city">Derby</addr-line>, <country>UK</country></aff><aff id="aff6"><label>6</label><institution content-type="department">Neurosurgery Department</institution>, <institution>University of Zambia University Teaching Hospital</institution>, <addr-line content-type="city">Lusaka</addr-line>, <country>Zambia</country></aff><aff id="aff7"><label>7</label><institution content-type="department">Department of Neurosurgery, Neurocenter</institution>, <institution>Oulu University Hospital</institution>, <addr-line content-type="city">Oulu</addr-line>, <country>Finland</country></aff><aff id="aff8"><label>8</label><institution>Centre Hospitalier R&#233;gional Universitaire de Tours</institution>, <addr-line content-type="city">Tours</addr-line>, <country>France</country></aff><aff id="aff9"><label>9</label><institution content-type="department">Department of Neurosurgery</institution>, <institution>Muhimbili Orthopaedic Institute</institution>, <addr-line content-type="city">Dar es Salaam</addr-line>, <country>Tanzania</country></aff><aff id="aff10"><label>10</label><institution>University of Malaya</institution>, <addr-line content-type="city">Kuala Lumpur</addr-line>, <country>Malaysia</country></aff><aff id="aff11"><label>11</label><institution>Tikur Anbessa Hospital</institution>, <addr-line content-type="city">Addis Ababa</addr-line>, <country>Ethiopia</country></aff><aff id="aff12"><label>12</label><institution content-type="department">Program in Global Surgery and Social Change</institution>, <institution>Harvard Medical School Department of Global Health and Social Medicine</institution>, <addr-line content-type="city">Boston</addr-line>, <addr-line content-type="state">Massachusetts</addr-line>, <country>USA</country></aff><aff id="aff13"><label>13</label><institution content-type="department">Department of Neurosurgery</institution>, <institution>University of Utah Health</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff><aff id="aff14"><label>14</label><institution>Universitas Pelita Harapan</institution>, <addr-line content-type="city">Tangerang</addr-line>, <country>Indonesia</country></aff><aff id="aff15"><label>15</label><institution content-type="department">Department of Epidemiology</institution>, <institution>Harvard T H Chan School of Public Health</institution>, <addr-line content-type="city">Boston</addr-line>, <addr-line content-type="state">Massachusetts</addr-line>, <country>USA</country></aff><aff id="aff16"><label>16</label><institution>Northwest General Hospital and Research Center</institution>, <addr-line content-type="city">Peshawar</addr-line>, <country>Pakistan</country></aff><aff id="aff17"><label>17</label><institution>University of Cape Town</institution>, <addr-line content-type="city">Rondebosch</addr-line>, <addr-line content-type="state">Western Cape</addr-line>, <country>South Africa</country></aff><aff id="aff18"><label>18</label><institution>Obex Technologies</institution>, <addr-line content-type="city">Cambridge</addr-line>, <country>UK</country></aff></contrib-group><author-notes><fn><p>Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></fn><fn fn-type="COI-statement" id="fn5"><p>None declared.</p></fn><corresp id="cor1">Dr Sara Venturini; <email xlink:href="sv465@cam.ac.uk">sv465@cam.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>9</month><year>2025</year></pub-date><volume>15</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496158</issue-id><elocation-id>e100361</elocation-id><history><date date-type="received"><day>13</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See:&#160;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="bmjopen-15-9.pdf"/><self-uri xlink:title="pdf" xlink:href="bmjopen-15-9.pdf"/><abstract><title>Abstract</title><sec><title>Introduction</title><p>Stroke is the second leading cause of death worldwide, with the greatest burden in low- and middle-income countries (LMICs). Haemorrhagic stroke or spontaneous intracranial haemorrhage (sICH), including intraparenchymal haemorrhage (IPH) and subarachnoid haemorrhage (SAH), has the highest mortality and morbidity. Local management practices for haemorrhagic stroke vary greatly between geographical regions. The Planetary Outcomes after Intracranial Haemorrhage study aims to provide a global snapshot of the patient characteristics, processes of care and short-term outcomes of patients being treated for sICH across high- and low-income settings. It will also describe variation seen in care processes and available resources and time delays to receiving care. A greater understanding of the current state of sICH care is essential to identify possible interventions and targets for improved standards of care in all settings.</p></sec><sec><title>Methods and analysis</title><p>We describe a planned prospective, multicentre, international observational cohort study of patients admitted to hospital for management of sICH. We will include patients of all ages presenting to hospital with imaging evidence of sICH (IPH, intraventricular haemorrhage and/or SAH). The study will collect patient, care process and short-term outcome data, following patients for up to 30 days (or until discharge or death, whichever occurs first). Any centre globally where patients with sICH are admitted and managed can participate, targeting a sample size of 712 patients. The study will recruit centres worldwide through pre-existing research networks and by dissemination through neurosurgical and stroke conferences and courses. Each participating centre will complete a site questionnaire alongside patient data collection.</p></sec><sec><title>Ethics and dissemination</title><p>The study has received ethical approval by the University of Cambridge (PRE.2024.070). Participating centres will also confirm that they have undergone all necessary local governance procedures prior to starting local data collection. The findings will be disseminated via open access peer-reviewed journals, relevant conferences and other professional networks and lay channels, including the study website (<ext-link xlink:href="https://plotich.org/" ext-link-type="uri">https://plotich.org/</ext-link>) and social media channels (@plotichstudy).</p></sec><sec><title>Trials registration number</title><p><ext-link xlink:href="NCT06731751" ext-link-type="ClinicalTrials.gov" specific-use="clinicaltrial none">NCT06731751</ext-link>.</p></sec></abstract><kwd-group><kwd>Stroke</kwd><kwd>Brain Injuries</kwd><kwd>Intracerebral Hemorrhage</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health and Care Research</institution></institution-wrap></funding-source><award-id>NIHR132455</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet" list-content="ul"><list-item><p>The Planetary Outcomes after Intracranial Haemorrhage study will use a collaborative research methodology to provide a global snapshot of current standards in care of patients with spontaneous intracranial haemorrhage (sICH), from the time of admission to the time of discharge or 30 days.</p></list-item><list-item><p>The data fields will include both patient and disease characteristics and care process information, providing information on clinical outcomes and healthcare system processes.</p></list-item><list-item><p>The study protocol has been developed by an international multidisciplinary panel of experts in brain injury (including stroke and neurovascular surgery), with extensive input from patient and public groups.</p></list-item><list-item><p>Key limitations of the study are that only short-term outcomes are collected, and that only patients reaching hospital for treatment of sICH are included, due to the pragmatic study design.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p> Stroke is the second leading cause of mortality worldwide and the third leading cause of death and disability combined.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> The global stroke incidence is reported at 12.2&#8201;million annually and is increasing, with over 80% of cases and associated morbidity and mortality occurring in low- and middle-income countries (LMICs).<xref rid="R1" ref-type="bibr"><sup>1 2</sup></xref> Stroke is a hallmark non-communicable disease that contributes significantly to the global disease burden and is now disproportionately affecting LMICs undergoing epidemiological transitions. There are now increasing concerns that this burden will continue to grow globally without reciprocated effective interventions.</p><p>Haemorrhagic strokes, that is, spontaneous intracranial haemorrhage (sICH), account for approximately one-third of the global stroke burden, with intraparenchymal haemorrhage (IPH) accounting for 27.9% and subarachnoid haemorrhage (SAH) accounting for 9.7% of all strokes, totalling a global estimated incidence of 4.59&#8201;million in 2019.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Despite being the minority of cases, IPH and SAH are responsible for the highest morbidity and mortality, and disproportionately affect younger individuals.<xref rid="R3" ref-type="bibr"><sup>3 4</sup></xref> Geographical variations exist, with IPH being two times as common in LMICs as in high-income countries (HICs) (29.5% vs 15.8%), while SAH is more common in HICs (7.9% vs 19.7%).<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> However, the true SAH incidence in LMICs is likely to be higher due to underreporting either because a significant proportion of individuals are not reaching hospitals or due to lack of access to neuroimaging to confirm the diagnosis.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> Several modifiable risk factors contribute to haemorrhagic stroke, such as hypertension, high body mass index and smoking, as well as environmental factors, such as air particle pollution, meaning that multiple areas for intervention are available.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Better understanding how these factors contribute to disease burden in different settings is important to develop targeted prevention strategies.</p><p>Management for sICH is multidisciplinary, with recent evidence suggesting that, in well-resourced healthcare settings, acute care bundles, including rapid access to imaging, blood pressure control, anticoagulant reversal and surgical referral for decision-making, improve outcomes.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> Processes of care, including diagnosis, referral and definitive treatment, vary depending on local pathways and resources. Diagnosis of underlying structural causes for the haemorrhage is essential, as this is more likely to require surgical intervention. This requires access to advanced neuroimaging, such as CT/magnetic resonance angiograms or formal cerebral angiograms to identify vascular abnormalities, such as aneurysms, arteriovenous malformations or dural arteriovenous fistulae and cavernomas. However, advanced diagnostics are not always available globally, resulting in diagnostic challenges, which, in turn, lead to missed opportunities for prompt treatment and prevention of disease sequelae.</p><p>Surgery (open surgical clipping or endovascular coiling) is often indicated in aneurysmal SAH.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> Endovascular treatments, which are becoming increasingly popular around the world, are not yet available in many resource-limited settings.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> Even when they are available in resource-limited settings, these interventions are particularly costly, further limiting their availability to only the wealthiest patients in these settings. Surgical clipping, if available, may be the only option in many LMICs.<xref rid="R9" ref-type="bibr"><sup>9 10</sup></xref> Even when available, delays to surgery can occur due to challenges in access to specialist services and resources, resulting in poorer outcomes than when surgery is performed without delay. Settings where neither treatment option is available are not uncommon in LMICs, and patients are, therefore, managed conservatively.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref></p><p>The role of surgery in IPH remains debated, with significant variation even across high-resource settings.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> For example, in the UK, management is primarily conservative under the care of stroke physicians in specialised hyperacute stroke units, whereas in Japan, surgery (often using minimally invasive procedures) is increasingly used.<xref rid="R12" ref-type="bibr"><sup>12 13</sup></xref> The STICH and STICH II trials showed no benefit of early surgical evacuation but were criticised for strict inclusion criteria.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref> A recent meta-analysis suggested possible benefits of (minimally invasive) clot evacuation early after symptom onset.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> The ENRICH trial showed that minimally invasive evacuation of a supratentorial lobar haemorrhage, when performed within 24 hours, is associated with better functional outcomes than medical management alone.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> For infratentorial IPH, such as intracerebellar haemorrhage, surgical evacuation is more common due to the posterior fossa compartment being more susceptible to mass effect.<xref rid="R17" ref-type="bibr"><sup>17 18</sup></xref></p><p>Despite a significant global sICH burden, there is still limited description of its full impact and outcomes, especially in LMICs. Understanding the worldwide variation in sICH-related morbidity, and how this relates to patient and health system factors, is needed to plan services and prioritise context-appropriate interventions.</p><sec id="s1-1"><title>Aim</title><p>The Planetary Outcomes after Intracranial Haemorrhage (PLOT-ICH) study aims to provide a global snapshot of patient characteristics, processes of care and clinical outcomes of patients being treated for sICH in high-, middle- and low-income settings. It will also describe the variation in available treatment modalities and resources and time delays to receiving care between clinical settings.</p></sec><sec id="s1-2"><title>Objectives</title><p>Specific objectives are as follows:</p><list list-type="bullet" list-content="ul"><list-item><p>estimate sICH case volume to gain insight into variations in epidemiology across world regions;</p></list-item><list-item><p>describe differences in patient baseline characteristics, presentation and risk factors;</p></list-item><list-item><p>describe the variation in available resources and management pathways for sICH;</p></list-item><list-item><p>describe the variation in non-operative and operative management strategies across income settings;</p></list-item><list-item><p>describe preoperative, perioperative and postoperative processes of care (including temporal delays to care);</p></list-item><list-item><p>identify possible indicators of high-quality care for sICH across income settings;</p></list-item><list-item><p>identify gaps in the implementation of best practices along the existing local pathways and care standards;</p></list-item><list-item><p>compare short-term clinical outcomes across high-, middle- and low-resource settings.</p></list-item></list></sec></sec><sec id="s2"><title>Methods and analysis</title><sec id="s2-1"><title>Study design</title><p>The PLOT-ICH study is a prospective multicentre observational cohort study of patients admitted to hospital for the management of sICH. A multicentre snapshot audit study design was chosen as this offers the opportunity to generate a large, diverse dataset representing many geographical regions, including those often under-represented in research, such as low-resource settings, as demonstrated by examples, such as the Global Neurotrauma Outcomes Study (GNOS), GNOS-Spine and GOAL Trauma studies.<xref rid="R19" ref-type="bibr"><sup>19 20</sup></xref> This approach encourages collaboration between centres worldwide, and a pragmatic data collection window (30 days) with a short follow-up period per participating centre facilitates contribution while minimising losses to follow-up and attrition related to prolonged data collection periods. These elements contribute to generating real-life data with findings that are impactful globally and delivered in a timely manner.</p><p>The core study team, comprising the steering committee and an advisory panel, who were involved in the study design and protocol writing, will oversee the study.</p></sec><sec id="s2-2"><title>Study setting and population</title><p>The study will recruit centres worldwide through pre-existing research networks and collaboratives, developed through the National Institute for Health and Care Research Global Health Research Groups on Neurotrauma and Acquired Brain and Spine Injury. Invitation to participate will also be extended through relevant professional societies and academic groups.</p><p>Any hospital admitting patients with sICH worldwide is eligible to participate. A minimum of one case must be submitted by each site during the 30-day chosen study period. At each site, the local team will comprise a local lead, up to two additional data collectors, a data validator and supervising clinician. The study recruitment is planned to run for a total of 12 months (February 2025&#8211;January 2026). Eligible patients presenting with sICH over a consecutive 30-day period chosen by each individual recruiting centre during the overall study period will be enrolled. Patients will be followed up until 30 days, death or discharge from hospital, whichever comes first. All data will be submitted to the central study team for inclusion in the final dataset. A minimum sample size of 712 patients will be recruited, as detailed in the Statistical Analysis section below.</p></sec><sec id="s2-3"><title>Patient and public involvement (PPI)</title><p>During the study protocol development, patient and public groups were involved. A PPI discussion took place, involving people with lived experiences of brain injury, relevant to the project. Individuals were consulted at multiple stages; they reviewed and provided feedback on written study documents, and a further online group discussion took place around the key study aims, data fields and outcomes. Feedback derived from this session was incorporated into and influenced aspects of the proposed methodology and outcomes. The PPI groups influenced the study design with regards to the overall study aims and study outcomes.</p></sec><sec id="s2-4"><title>Eligibility criteria</title><p>The study will include patients of any age meeting the case definition criteria and admitted to a participating institution with an sICH during the selected 30-day study period. The case definition is:</p><list list-type="bullet" list-content="ul"><list-item><p>patients of any age with the presence of sICH (IPH, intraventricular haemorrhage and/or SAH haemorrhage) on intracranial imaging, in the absence of a definite history of head trauma, or other clinical features highly suggestive of head trauma;</p></list-item><list-item><p>hospital admission for sICH management. This includes admission for observation, conservative or interventional management to both ward-based and critical care settings.</p></list-item></list><p>A patient will be included in the final analysis if&gt;70% of the data fields required have been recorded.</p><p>Exclusion criteria are as follows:</p><list list-type="bullet" list-content="ul"><list-item><p>patients who have a clear history of head trauma as the primary cause of the haemorrhage and, therefore, are diagnosed with traumatic intracranial haemorrhage;</p></list-item><list-item><p>patients with subdural or extradural haematomas but no clear history of trauma;</p></list-item><list-item><p>patients with intracranial haemorrhage occurring as a complication of a procedure or intervention (eg, postoperative haematoma) or iatrogenic (eg, after thrombolysis for ischaemic stroke);</p></list-item><list-item><p>patients who are admitted for elective (planned admission to hospital) or semielective (where a patient was initially admitted to hospital, then discharged from hospital and readmitted for surgery) procedures;</p></list-item><list-item><p>patients readmitted to hospital within 30 days of the initial admission with sICH (including those readmitted for acute management of sICH-related complications);</p></list-item><list-item><p>patient presenting to the emergency department (ED) but discharged home from the ED immediately without a period of observation or admission to a ward.</p></list-item></list></sec><sec id="s2-5"><title>Data collection and storage</title><p>Data will be collected from consecutive patients who met the inclusion criteria during the study period. The dataset contains five sections: baseline data, imaging data, acute management data, operative or interventional data (if applicable) and outcome data (see <xref rid="SP1" ref-type="supplementary-material">online supplemental material</xref>). The data points were determined through consultation with clinicians from a range of income settings. Only pseudonymised data will be collected on the online platform, and anonymised data will be accessed by the central study team.</p><sec id="s2-5-1"><title>Outcome measures</title><p>The primary outcome of the study is 30-day mortality or survival to hospital discharge (whichever comes first). Participating centres will be stratified according to income settings, and mortality rates will be compared across cohorts defined by income groups.</p><p>Secondary outcome measures include:</p><list list-type="bullet" list-content="ul"><list-item><p>perioperative complications, including but not limited to surgical site infections;</p></list-item><list-item><p>clinical outcomes other than mortality, measured through:</p><list list-type="bullet" list-content="ul"><list-item><p>Glasgow coma scale at discharge;</p></list-item><list-item><p>modified Rankin scale.</p></list-item></list></list-item><list-item><p>Length of hospital stay and intensive care unit stay.</p></list-item></list><p>Each unit will be asked to complete a questionnaire on care processes and resources available. This will describe local case load, catchment population and referral pathways, and management frameworks and infrastructure at prehospital and hospital level.</p><p>Data will be collected and stored exclusively on a secure web-based system within the Outcome Registry Intervention and Operation Network platform <ext-link xlink:href="https://orion.net/" ext-link-type="uri">https://orion.net/</ext-link>. This will enable secure data collection, validation and storage in a standard format, which is compliant with the UK National Health Service (NHS) security standards (including the Information Governance Toolkit). All patient data will be recorded and held anonymously. A pilot phase was conducted to assess feasibility prior to rolling out the full study.</p></sec></sec><sec id="s2-6"><title>Statistical analysis</title><p>A formal a priori statistical plan will be produced for data analysis. In short, the primary analysis will comprise statistical descriptive analysis of patient-level variables and the characterisation of processes of care using descriptions of provider profiling data and patient-level process variables.</p><p>Country groups will be defined using the human development index (HDI), a recognised index of human development.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> The 30-day mortality will be reported for each HDI tier. Further analyses will stratify against other indices of economic development and health. Multivariable logistic regression models will be used to investigate the primary and secondary outcomes. Provider profile summaries will be compared with current evidence-based best practices to identify gaps and associations with care processes and case mix.</p><p>There is limited robust epidemiological data on sICH globally across income settings, with mortality rates for hospital cohorts reported between 20% and 33% in HICs and 39% and 62% in LMICs.<xref rid="R22" ref-type="bibr">22</xref><xref rid="R28" ref-type="bibr">28</xref> Therefore, an accurate sample size calculation is not feasible. However, taking conservative mortality estimates indicating a 30-day mortality rate for sICH of around 30% in HICs and up to 40% in LMICs, using an alpha value of 0.05 and power of 80% to show a 10% difference between HIC and LMIC settings, a total of 712 patients would need to be recruited. Subgroup analyses will be performed, for example, to describe differences between sICH subtypes or hospital type.</p><p>Based on the data and experience from other observational studies with a similar methodology, we would expect that each centre enrols around three to five patients over a 30-day study period.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> Therefore, with around 150 recruiting centres from our pre-existing research network, we would expect to meet and exceed the sample size required. Given the nature of this international study, missing values are expected and could affect some participating centres more than others. Patients with at least 70% data field completeness will be included in the analysis. At each site, a data validator, independent from the primary data collectors, will validate accuracy for key study variables to ensure completeness and data accuracy.</p></sec><sec id="s2-7"><title>Limitations</title><p>There are limitations worth noting in this study. First, long-term follow-up data are not feasible for this study design. Additionally, this pragmatic study will only include patients reaching hospital for their sICH and, therefore, cannot provide comprehensive data on population-level sICH disease burden. Data validation will ensure robustness of the dataset; however, some missing data are expected in this collaborative study. Finally, this study will not test the efficacy of specific management strategies or novel interventions for patients with sICH.</p></sec><sec id="s2-8"><title>Ethics and dissemination</title><p>The study received ethical approval from the University of Cambridge Psychology Research Ethics Committee (PRE.2024.070). Using the UK NHS Health Research Authority tool (<ext-link xlink:href="https://www.hra-decisiontools.org.uk/research/" ext-link-type="uri">https://www.hra-decisiontools.org.uk/research/</ext-link>),<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> this study is considered locally as a clinical evaluation study in the UK and will need to be registered as such at each participating site. In this setting, no formal informed consent is required, as data fields relate to those routinely collected as a part of standard clinical care. All participating centres will confirm that they have undergone all necessary local governance procedures prior to starting local data collection. Ethical approval processes and regulations vary between countries and obtaining informed consent from participants may be needed in some settings. We have prepared patient information sheets and consent forms for participating sites requiring these, in accordance with local regulatory processes. We expect that many participating sites will have access to waived consent procedures for the type of data collected in this study, which has been the case for large observational studies with similar methodologies.<xref rid="R19" ref-type="bibr"><sup>19 30</sup></xref> All data will be anonymised before it is accessed by the central study team. The study has been registered to ClinicalTrials.gov (<ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06731751">NCT06731751</ext-link>) and will be reported using the Strengthening the Reporting of Observational Studies in Epidemiology statement guidelines and checklists.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> The study website <ext-link xlink:href="http://www.plotich.org" ext-link-type="uri">www.plotich.org</ext-link> can also be accessed for all study documentations.</p><p>A full report of the study will be produced and published in an open access peer-reviewed journal with global readership. We expect many collaborators in this study; a collaborative authorship model will be used for all publications derived from the study itself, as outlined in the Guidelines for Standardising Reporting of Authorship in Collaborative Research.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref></p><p>Results will also be communicated through presentation at relevant conferences and meetings, including existing international collaborator network and societies. Each participating site will also have access to their local data for presentation at institutional level. Lay-facing summaries of the results will be produced and shared with relevant stakeholders, communities and patient groups.</p></sec></sec><sec sec-type="supplementary-material" id="s3"><title>Supplementary material</title><supplementary-material id="SP1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2025-100361</object-id><label>online supplemental file 1</label><media xlink:href="bmjopen-15-9-s001.docx" id="d67e760" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This research was funded by the NIHR ref: NIHR132455 using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK government. The funder was not involved in the study development or manuscript preparation.</p></fn><fn fn-type="other"><p>Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (<ext-link xlink:href="https://doi.org/10.1136/bmjopen-2025-100361" ext-link-type="uri">https://doi.org/10.1136/bmjopen-2025-100361</ext-link>).</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Not applicable.</p></fn><fn fn-type="other"><p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2019 Stroke Collaborators</collab></person-group><article-title>Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title><source>Lancet Neurol</source><year>2019</year><volume>20</volume><fpage>795</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(21)00252-0</pub-id><pub-id pub-id-type="pmcid">PMC8443449</pub-id><pub-id pub-id-type="pmid">34487721</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name><name name-style="western"><surname>Brainin</surname><given-names>M</given-names></name><name name-style="western"><surname>Norrving</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>World Stroke Organization (WSO): Global Stroke Fact Sheet 2022</article-title><source>Int J Stroke</source><year>2022</year><volume>17</volume><fpage>18</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1177/17474930211065917</pub-id><pub-id pub-id-type="pmid">34986727</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnamurthi</surname><given-names>RV</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name></person-group><article-title>Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017</article-title><source>Neuroepidemiology</source><year>2020</year><volume>54</volume><fpage>171</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1159/000506396</pub-id><pub-id pub-id-type="pmid">32079017</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etminan</surname><given-names>N</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H-S</given-names></name><name name-style="western"><surname>Hackenberg</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis</article-title><source>JAMA Neurol</source><year>2019</year><volume>76</volume><fpage>588</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2019.0006</pub-id><pub-id pub-id-type="pmid">30659573</pub-id><pub-id pub-id-type="pmcid">PMC6515606</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogungbo</surname><given-names>B</given-names></name><name name-style="western"><surname>Mendelow</surname><given-names>AD</given-names></name><name name-style="western"><surname>Walker</surname><given-names>R</given-names></name></person-group><article-title>The epidemiology, diagnosis and treatment of subarachnoid haemorrhage in Nigeria: what do we know and what do we need to know?</article-title><source>Br J Neurosurg</source><year>2004</year><volume>18</volume><fpage>362</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1080/02688690400005057</pub-id><pub-id pub-id-type="pmid">15702835</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parry-Jones</surname><given-names>AR</given-names></name><name name-style="western"><surname>J&#228;rhult</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kreitzer</surname><given-names>N</given-names></name><etal>et al</etal></person-group><article-title>Acute care bundles should be used for patients with intracerebral haemorrhage: An expert consensus statement</article-title><source>Eur Stroke J</source><year>2024</year><volume>9</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1177/23969873231220235</pub-id><pub-id pub-id-type="pmid">38149323</pub-id><pub-id pub-id-type="pmcid">PMC11318433</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Connolly</surname><given-names>ES</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Rabinstein</surname><given-names>AA</given-names></name><name name-style="western"><surname>Carhuapoma</surname><given-names>JR</given-names></name><etal>et al</etal></person-group><article-title>Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage</article-title><source>Stroke</source><year>2012</year><volume>43</volume><fpage>1711</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1161/STR.0b013e3182587839</pub-id><pub-id pub-id-type="pmid">22556195</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dokponou</surname><given-names>YCH</given-names></name><name name-style="western"><surname>Kotecha</surname><given-names>J</given-names></name><name name-style="western"><surname>Bandyopadhyay</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Continental Survey of Access to Diagnostic Tools and Endovascular Management of Aneurysmal Subarachnoid Hemorrhage in Africa</article-title><source>Front Surg</source><year>2021</year><volume>8</volume><elocation-id>690714</elocation-id><pub-id pub-id-type="doi">10.3389/fsurg.2021.690714</pub-id><pub-id pub-id-type="pmid">34355014</pub-id><pub-id pub-id-type="pmcid">PMC8329527</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waterkeyn</surname><given-names>F</given-names></name><name name-style="western"><surname>Lohkamp</surname><given-names>L-N</given-names></name><name name-style="western"><surname>Ikwuegbuenyi</surname><given-names>CA</given-names></name><etal>et al</etal></person-group><article-title>Current Treatment Management of Aneurysmal Subarachnoid Hemorrhage with Prevailing Trends and Results in Tanzania: A Single-Center Experience at Muhimbili Orthopedic and Neurosurgery Institute</article-title><source>World Neurosurg</source><year>2023</year><volume>170</volume><fpage>e256</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2022.11.003</pub-id><pub-id pub-id-type="pmid">36336272</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="preprint"><person-group person-group-type="author"><name name-style="western"><surname>Ferraris</surname><given-names>KP</given-names></name><name name-style="western"><surname>Golidtum</surname><given-names>JP</given-names></name><name name-style="western"><surname>Palabyab</surname><given-names>EPM</given-names></name><etal>et al</etal></person-group><article-title>Predictors of poor outcome from aneurysmal subarachnoid hemorrhage and an exploratory analysis into the causes of delayed neurosurgical clipping at a major public hospital in the philippines</article-title><source>In Review</source><comment>Preprint</comment><year>2023</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-405670/v2</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobata</surname><given-names>H</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>N</given-names></name></person-group><article-title>Recent Updates in Neurosurgical Interventions for Spontaneous Intracerebral Hemorrhage: Minimally Invasive Surgery to Improve Surgical Performance</article-title><source>Front Neurol</source><year>2021</year><volume>12</volume><pub-id pub-id-type="doi">10.3389/fneur.2021.703189</pub-id><pub-id pub-id-type="pmcid">PMC8326326</pub-id><pub-id pub-id-type="pmid">34349724</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tahara</surname><given-names>S</given-names></name><name name-style="western"><surname>Hattori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Aso</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Trends in surgical procedures for spontaneous intracerebral hemorrhage in Japan</article-title><source>J Stroke Cerebrovasc Dis</source><year>2022</year><volume>31</volume><fpage>106664</fpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2022.106664</pub-id><pub-id pub-id-type="pmid">35908346</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toyoda</surname><given-names>K</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>T</given-names></name><name name-style="western"><surname>Epple</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Comparison of the European and Japanese Guidelines for the Acute Management of Intracerebral Hemorrhage</article-title><source>Cerebrovasc Dis</source><year>2013</year><volume>35</volume><fpage>419</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1159/000351754</pub-id><pub-id pub-id-type="pmid">23712243</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendelow</surname><given-names>AD</given-names></name><name name-style="western"><surname>Gregson</surname><given-names>BA</given-names></name><name name-style="western"><surname>Rowan</surname><given-names>EN</given-names></name><etal>et al</etal></person-group><article-title>Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial</article-title><source>The Lancet</source><year>2013</year><volume>382</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60986-1</pub-id><pub-id pub-id-type="pmcid">PMC3906609</pub-id><pub-id pub-id-type="pmid">23726393</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sondag</surname><given-names>L</given-names></name><name name-style="western"><surname>Schreuder</surname><given-names>FHBM</given-names></name><name name-style="western"><surname>Boogaarts</surname><given-names>HD</given-names></name><etal>et al</etal></person-group><article-title>Neurosurgical Intervention for Supratentorial Intracerebral Hemorrhage</article-title><source>Ann Neurol</source><year>2020</year><volume>88</volume><fpage>239</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/ana.25732</pub-id><pub-id pub-id-type="pmid">32239722</pub-id><pub-id pub-id-type="pmcid">PMC7497162</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pradilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Ratcliff</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Hall</surname><given-names>AJ</given-names></name><etal>et al</etal></person-group><article-title>Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage</article-title><source>N Engl J Med</source><year>2024</year><volume>390</volume><fpage>1277</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2308440</pub-id><pub-id pub-id-type="pmid">38598795</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luney</surname><given-names>MS</given-names></name><name name-style="western"><surname>English</surname><given-names>SW</given-names></name><name name-style="western"><surname>Longworth</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Acute Posterior Cranial Fossa Hemorrhage&#8212;Is Surgical Decompression Better than Expectant Medical Management?</article-title><source>Neurocrit Care</source><year>2016</year><volume>25</volume><fpage>365</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s12028-015-0217-7</pub-id><pub-id pub-id-type="pmid">27071924</pub-id><pub-id pub-id-type="pmcid">PMC5138260</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satop&#228;&#228;</surname><given-names>J</given-names></name><name name-style="western"><surname>Meretoja</surname><given-names>A</given-names></name><name name-style="western"><surname>Koivunen</surname><given-names>RJ</given-names></name><etal>et al</etal></person-group><article-title>Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality</article-title><source>Surg Neurol Int</source><year>2017</year><volume>8</volume><elocation-id>272</elocation-id><pub-id pub-id-type="doi">10.4103/sni.sni_168_17</pub-id><pub-id pub-id-type="pmid">29204307</pub-id><pub-id pub-id-type="pmcid">PMC5691556</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>D</given-names></name><name name-style="western"><surname>Joannides</surname><given-names>A</given-names></name><name name-style="western"><surname>Adeleye</surname><given-names>AO</given-names></name><etal>et al</etal></person-group><article-title>Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study</article-title><source>Lancet Neurol</source><year>2022</year><volume>21</volume><fpage>438</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(22)00037-0</pub-id><pub-id pub-id-type="pmid">35305318</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bath</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>K</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Evaluating patient factors, operative management and postoperative outcomes in trauma laparotomy patients worldwide: a protocol for a global observational multicentre trauma study</article-title><source>BMJ Open</source><year>2024</year><volume>14</volume><elocation-id>e083135</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2023-083135</pub-id><pub-id pub-id-type="pmcid">PMC11002395</pub-id><pub-id pub-id-type="pmid">38580358</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Human Development Index</collab></person-group><article-title>Human development reports</article-title><publisher-loc>United Nations</publisher-loc><comment>Available</comment><ext-link xlink:href="https://hdr.undp.org/data-center/human-development-index#/indicies/HDI" ext-link-type="uri">https://hdr.undp.org/data-center/human-development-index#/indicies/HDI</ext-link><comment>accessed</comment><date-in-citation>24-Jan-2025</date-in-citation></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asikainen</surname><given-names>A</given-names></name><name name-style="western"><surname>Korja</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaprio</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Case Fatality in Patients With Aneurysmal Subarachnoid Hemorrhage in Finland</article-title><source>Neurology (ECronicon)</source><year>2023</year><volume>100</volume><pub-id pub-id-type="doi">10.1212/WNL.0000000000201402</pub-id><pub-id pub-id-type="pmid">36257709</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernando</surname><given-names>SM</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>D</given-names></name><name name-style="western"><surname>Talarico</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use</article-title><source>Stroke</source><year>2021</year><volume>52</volume><fpage>1673</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032550</pub-id><pub-id pub-id-type="pmid">33685222</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safatli</surname><given-names>DA</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>A</given-names></name><name name-style="western"><surname>Schlattmann</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage</article-title><source>Surg Neurol Int</source><year>2016</year><volume>7</volume><fpage>510</fpage><pub-id pub-id-type="doi">10.4103/2152-7806.187493</pub-id><pub-id pub-id-type="pmcid">PMC4982350</pub-id><pub-id pub-id-type="pmid">27583176</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razzaq</surname><given-names>AA</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>R</given-names></name></person-group><article-title>Determinants of 30-day mortality of spontaneous intracerebral hemorrhage in Pakistan</article-title><source>Surg Neurol</source><year>1998</year><volume>50</volume><fpage>336</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S0090-3019(98)00089-5</pub-id><pub-id pub-id-type="pmid">9817456</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oveisgharan</surname><given-names>S</given-names></name><name name-style="western"><surname>Sarrafzadegan</surname><given-names>N</given-names></name><name name-style="western"><surname>Shirani</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate</article-title><source>Cerebrovasc Dis</source><year>2007</year><volume>24</volume><fpage>495</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1159/000110418</pub-id><pub-id pub-id-type="pmid">17971627</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagui</surname><given-names>E</given-names></name><name name-style="western"><surname>M&#8217;Baye</surname><given-names>PS</given-names></name><name name-style="western"><surname>Dubecq</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Ischemic and hemorrhagic strokes in Dakar, Senegal: a hospital-based study</article-title><source>Stroke</source><year>2005</year><volume>36</volume><fpage>1844</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000177864.08516.47</pub-id><pub-id pub-id-type="pmid">16081856</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>B-W</given-names></name></person-group><article-title>Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update</article-title><source>J Stroke</source><year>2017</year><volume>19</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.5853/jos.2016.00864</pub-id><pub-id pub-id-type="pmid">28178408</pub-id><pub-id pub-id-type="pmcid">PMC5307940</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="webpage"><article-title>Is my study research?</article-title><comment>Available</comment><ext-link xlink:href="https://www.hra-decisiontools.org.uk/research/" ext-link-type="uri">https://www.hra-decisiontools.org.uk/research/</ext-link><comment>Accessed</comment><date-in-citation>24-Jan-2025</date-in-citation></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biccard</surname><given-names>BM</given-names></name><name name-style="western"><surname>Madiba</surname><given-names>TE</given-names></name><name name-style="western"><surname>Kluyts</surname><given-names>H-L</given-names></name><etal>et al</etal></person-group><article-title>Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study</article-title><source>Lancet</source><year>2018</year><volume>391</volume><fpage>1589</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)30001-1</pub-id><pub-id pub-id-type="pmid">29306587</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="webpage"><article-title>The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies</article-title><comment>Available</comment><ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">https://www.equator-network.org/reporting-guidelines/strobe/</ext-link><comment>Accessed</comment><date-in-citation>23-Jan-2025</date-in-citation><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.39335.541782.AD</pub-id><pub-id pub-id-type="pmcid">PMC2034723</pub-id><pub-id pub-id-type="pmid">17947786</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Research Collaborative &amp; Association of Surgeons in Training Collaborative Consensus Group</collab></person-group><article-title>Recognising contributions to work in research collaboratives: Guidelines for standardising reporting of authorship in collaborative research</article-title><source>Int J Surg</source><year>2018</year><volume>52</volume><fpage>355</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">29292217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijsu.2017.12.019</pub-id></element-citation></ref></ref-list></back><sub-article id="sub-article1" article-type="aggregated-review-documents"><front-stub><title-group><article-title>Review Process File</article-title></title-group><pub-date pub-type="epub"><day>02</day><month>09</month><year>2025</year></pub-date></front-stub><body><fig id="d67e1555" position="anchor" orientation="portrait"><media xlink:href="bmjopen-2025-100361.reviewer_comments.pdf" position="float" orientation="portrait"/></fig></body></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>